| Which sources do you consult in order to get informed about the ADRs of a drug? | |||
---|---|---|---|---|
 | Greece | Cyprus | Difference | p-value |
National Medicines Organization | 65.70% | 48.70% | 17.00% | 0.000 |
Internet | 33.06% | 37.82% | -4.76% | 0.200 |
Pharmaceutical representatives | 42.61% | 41.97% | 0.64% | 0.866 |
Media | 16.86% | 11.92% | 4.94% | 0.052 |
Colleagues | 38.54% | 21.24% | 17.30% | 0.000 |
Other | 4.32% | 11.40% | 7.08% | 0.001 |
 | The appearance of ADRs affects your prescribing decision? | |||
 | Greece | Cyprus | Difference | p-value |
Very much | 51.21% | 43.01% | 8.20% | 0.030 |
A lot | 43.13% | 47.15% | -4.02% | 0.300 |
A little | 4.91% | 9.84% | -4.93% | 0.026 |
Not at all | 0.75% | 0.00% | 0.75% | 0.000 |
 | How many times have an ADR appeared in your patients in the past two years? | |||
 | Greece | Cyprus | Difference | p-value |
None | 46.68% | 8.81% | 37.87% | 0.000 |
1–5 times | 46.26% | 57.51% | -11.25% | 0.004 |
6–10 times | 5.04% | 19.69% | -14.65% | 0.000 |
More | 2.02% | 13.99% | -11.97% | 0.000 |
 | For such cases did you send a "yellow card*" to inform the authorities? | |||
 | Greece | Cyprus | Difference | p-value |
Yes | 37.43% | 11.92% | 25.51% | 0.000 |
No | 62.57% | 88.08% | -25.51% | 0.000 |